Fintel reports that on October 21, 2025, Barclays maintained coverage of RAPT Therapeutics (NasdaqGM:RAPT) with a Overweight ...

Fintel reports that on October 21, 2025, HC Wainwright & Co. reiterated coverage of Cidara Therapeutics (NasdaqCM:CDTX) with ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

Prosper Junior Bakiny has positions in Eli Lilly and Viking Therapeutics. The Motley Fool recommends Viking Therapeutics. The ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $5.62, a high estimate of $7.00, and a low estimate of $3.50. This current average has increased by 60.57% ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

Sionna Therapeutics said it started a Phase 2a proof-of-concept trial evaluating the results of SION-719, a nucleotide binding domain (NBD1) stabilizer, when added to Trikafta, which is the current ...

Analysts' ratings for Protagonist Therapeutics (NASDAQ:PTGX) over the last quarter vary from bullish to bearish, as provided ...

Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc.

Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 17, Summit Therapeutics Inc.